{
  "id": 566,
  "text": "</td><td>Conditional recommendation, low-certainty evidence</td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negative, are retested again at 12 months and, if negative again, move to the recommended regular screening interval.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: </td><td>Conditional recommendation, low-certainty evidence</td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negative, are retested agai\n\n<question>: ",
  "ChatGPT_response_0": "根据世界卫生组织的建议，对于生活在艾滋病毒患者中，经过组织学确诊的CIN2/3或混合瓦斯腺癌（AlS）治疗，或因为阳性筛查测试而接受治疗的妇女，在进行再测试时，最有效的方式是使用HPV DNA测试。此测试可以在12个月后进行，而非使用细胞学或病毒载量或联合检测。如果在第一次测试时结果为阴性，建议再次在12个月后进行测试，如果再次为阴性，则可以按照推荐的常规检查间隔进行后续筛查。",
  "query": "对于生活在艾滋病毒患者中，如果经过组织学确诊的CIN2/3或混合瓦斯腺癌（AlS）治疗，或因为阳性筛查测试而接受治疗，WHO建议在12个月进行HPV DNA测试。在这种情况下，你认为对于这些妇女而言，什么是最有效的再测试方式？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于生活在艾滋病毒患者中，如果经过组织学确诊的CIN2/3或混合瓦斯腺癌（AlS）治疗，或因为阳性筛查测试而接受治疗，WHO建议在12个月进行HPV DNA测试。在这种情况下，你认为对于这些妇女而言，什么是最有效的再测试方式？\n\n<reference text>: </td><td>Conditional recommendation, low-certainty evidence</td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negative, are retested again at 12 months and, if negative again, move to the recommended regular screening interval.\n\n<reply>: ",
  "response": "根据世界卫生组织的建议，对于生活在艾滋病毒患者中，经过组织学确诊的CIN2/3或混合瓦斯腺癌（AlS）治疗，或因为阳性筛查测试而接受治疗的妇女，在进行再测试时，最有效的方式是使用HPV DNA测试。此测试可以在12个月后进行，而非使用细胞学或病毒载量或联合检测。如果在第一次测试时结果为阴性，建议再次在12个月后进行测试，如果再次为阴性，则可以按照推荐的常规检查间隔进行后续筛查。"
}